These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 39296215)
1. Hepatic Dyrk1b impairs systemic glucose homeostasis by modulating Wbp2 expression in a kinase activity-dependent manner. Li L; Zou Y; Shen C; Chen N; Tong M; Liu R; Wang J; Ning G Heliyon; 2024 Sep; 10(17):e36726. PubMed ID: 39296215 [TBL] [Abstract][Full Text] [Related]
2. Dyrk1b promotes hepatic lipogenesis by bypassing canonical insulin signaling and directly activating mTORC2 in mice. Bhat N; Narayanan A; Fathzadeh M; Kahn M; Zhang D; Goedeke L; Neogi A; Cardone RL; Kibbey RG; Fernandez-Hernando C; Ginsberg HN; Jain D; Shulman GI; Mani A J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34855620 [TBL] [Abstract][Full Text] [Related]
3. A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr(286), not Thr(288). Ashford AL; Oxley D; Kettle J; Hudson K; Guichard S; Cook SJ; Lochhead PA Biochem J; 2014 Jan; 457(1):43-56. PubMed ID: 24134204 [TBL] [Abstract][Full Text] [Related]
4. WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ. Chan SW; Lim CJ; Huang C; Chong YF; Gunaratne HJ; Hogue KA; Blackstock WP; Harvey KF; Hong W Oncogene; 2011 Feb; 30(5):600-10. PubMed ID: 20972459 [TBL] [Abstract][Full Text] [Related]
5. WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer. Chen S; Wang H; Huang YF; Li ML; Cheng JH; Hu P; Lu CH; Zhang Y; Liu N; Tzeng CM; Zhang ZM Mol Cancer; 2017 Jul; 16(1):128. PubMed ID: 28724435 [TBL] [Abstract][Full Text] [Related]
6. WW domain-binding protein 2 overexpression prevents diet-induced liver steatosis and insulin resistance through AMPKβ1. Zheng Z; Li Y; Fan S; An J; Luo X; Liang M; Zhu F; Huang K Cell Death Dis; 2021 Mar; 12(3):228. PubMed ID: 33658485 [TBL] [Abstract][Full Text] [Related]
7. [Expression and clinical significance of Dyrk1b in the specimens and cells of cervical lesions]. Lin J; Zhang P; Pang L; Chen J; Sun W; Qi W; Lyu Y; Guan H; Gao J Zhonghua Fu Chan Ke Za Zhi; 2016 Jan; 51(1):40-5. PubMed ID: 26899006 [TBL] [Abstract][Full Text] [Related]
8. The transcriptional coactivator WBP2 primes triple-negative breast cancer cells for responses to Wnt signaling via the JNK/Jun kinase pathway. Li Z; Lim SK; Liang X; Lim YP J Biol Chem; 2018 Dec; 293(52):20014-20028. PubMed ID: 30442712 [TBL] [Abstract][Full Text] [Related]
9. WW domain-binding protein 2 acts as an oncogene by modulating the activity of the glycolytic enzyme ENO1 in glioma. Chen S; Zhang Y; Wang H; Zeng YY; Li Z; Li ML; Li FF; You J; Zhang ZM; Tzeng CM Cell Death Dis; 2018 Mar; 9(3):347. PubMed ID: 29497031 [TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation of transcriptional coactivator WW-domain binding protein 2 regulates estrogen receptor α function in breast cancer via the Wnt pathway. Lim SK; Orhant-Prioux M; Toy W; Tan KY; Lim YP FASEB J; 2011 Sep; 25(9):3004-18. PubMed ID: 21642474 [TBL] [Abstract][Full Text] [Related]
11. Transcription factor TIP27 regulates glucose homeostasis and insulin sensitivity in a PI3-kinase/Akt-dependent manner in mice. Yuan L; Luo X; Zeng M; Zhang Y; Yang M; Zhang L; Liu R; Boden G; Liu H; Ma ZA; Li L; Yang G Int J Obes (Lond); 2015 Jun; 39(6):949-58. PubMed ID: 25614086 [TBL] [Abstract][Full Text] [Related]
12. microRNA-485-5p inhibits the progression of hepatocellular carcinoma through blocking the WBP2/Wnt signaling pathway. Gao J; Dai C; Yu X; Yin XB; Zhou F Cell Signal; 2020 Feb; 66():109466. PubMed ID: 31706018 [TBL] [Abstract][Full Text] [Related]
13. Growth hormone receptor disrupts glucose homeostasis via promoting and stabilizing retinol binding protein 4. Liu J; Nie C; Xue L; Yan Y; Liu S; Sun J; Fan M; Qian H; Ying H; Wang L; Li Y Theranostics; 2021; 11(17):8283-8300. PubMed ID: 34373742 [No Abstract] [Full Text] [Related]
14. Wnt Signaling Promotes Breast Cancer by Blocking ITCH-Mediated Degradation of YAP/TAZ Transcriptional Coactivator WBP2. Lim SK; Lu SY; Kang SA; Tan HJ; Li Z; Adrian Wee ZN; Guan JS; Reddy Chichili VP; Sivaraman J; Putti T; Thike AA; Tan PH; Sudol M; Virshup DM; Chan SW; Hong W; Lim YP Cancer Res; 2016 Nov; 76(21):6278-6289. PubMed ID: 27578003 [TBL] [Abstract][Full Text] [Related]
15. The role of skeletal muscle Akt in the regulation of muscle mass and glucose homeostasis. Jaiswal N; Gavin MG; Quinn WJ; Luongo TS; Gelfer RG; Baur JA; Titchenell PM Mol Metab; 2019 Oct; 28():1-13. PubMed ID: 31444134 [TBL] [Abstract][Full Text] [Related]
16. Mirk/Dyrk1B controls ventral spinal cord development via Shh pathway. Kokkorakis N; Douka K; Nalmpanti A; Politis PK; Zagoraiou L; Matsas R; Gaitanou M Cell Mol Life Sci; 2024 Jan; 81(1):70. PubMed ID: 38294527 [TBL] [Abstract][Full Text] [Related]
17. Dietary glycation compounds - implications for human health. Hellwig M; Diel P; Eisenbrand G; Grune T; Guth S; Henle T; Humpf HU; Joost HG; Marko D; Raupbach J; Roth A; Vieths S; Mally A Crit Rev Toxicol; 2024 Sep; 54(8):485-617. PubMed ID: 39150724 [TBL] [Abstract][Full Text] [Related]
18. WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression. Han Q; Rong X; Lin X; Zhang X; Fan C; Zhao H; Wang E Cell Death Dis; 2021 Apr; 12(4):384. PubMed ID: 33837178 [TBL] [Abstract][Full Text] [Related]
19. Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor Dicer. Lim SK; Tabatabaeian H; Lu SY; Kang SA; Sundaram GM; Sampath P; Chan SW; Hong WJ; Lim YP Cell Death Dis; 2020 Aug; 11(8):669. PubMed ID: 32820148 [TBL] [Abstract][Full Text] [Related]
20. WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple-negative breast cancer via NF-κB activation. Lim YX; Lin H; Chu T; Lim YP Mol Oncol; 2022 Jan; 16(2):422-446. PubMed ID: 34197030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]